Search for: "Max Factor & Co. v. Factor"
Results 61 - 80
of 86
Sort by Relevance
|
Sort by Date
3 Jan 2012, 10:20 am
© Max Kennerly. [read post]
15 Dec 2011, 6:25 am
Dukes and AT&T Mobility v. [read post]
30 Nov 2011, 2:15 pm
Okay, so here’s the next installment of Mandelman’s Monthly Museletter, which I’ve decided I post whenever there are a bunch of things going on that need to be put into proper perspective, but there’s just no way I can write individual articles on each because to do so presents a serious health risk. [read post]
21 Nov 2011, 10:07 am
Nightrider sues Max, and Max wins a verdict after trial with a special verdict from the jury finding Max was not negligent. [read post]
26 Aug 2011, 7:05 am
Metropolitan Contracting Co., ‘It is unquestionably true, as declared in Haneman v. [read post]
20 Feb 2011, 9:44 pm
(Reexamination Alert) Recapture doctrine before the CAFC: In re Mostafazedeh (Patents Post-Grant) US Patents – Decisions District Court S D New York: Patentee’s ‘sufficiently plausible’ belief as to the scope of patents negates intent to deceive necessary for false marking claim: Max Impact v Sherwood Group (Docket Report) District Court E D Texas – Marshall jury verdict for plaintiff; invalidity rejected even under ‘preponderance’… [read post]
7 Feb 2011, 2:58 am
Schreurs & Co. [read post]
30 Dec 2010, 2:13 pm
In United States v. [read post]
16 Dec 2010, 4:40 am
Following are factors, though not all inclusive, to be considered in assessing higher custody classifications (MAX or MDI): a. [read post]
3 Dec 2010, 12:50 pm
Another factor cited was the effort by the courts to prevent forum shopping by plaintiffs. [read post]
30 Aug 2010, 7:07 am
Several years later I met Max – incredible Renaissance man! [read post]
28 Jun 2010, 3:08 am
(formerly Merck & Co. [read post]
27 Jun 2010, 6:00 pm
(formerly Merck & Co. [read post]
1 Apr 2010, 3:04 am
USPTO and Myriad Genetics (Docket Report) (Peter Zura's 271 Patent Blog) (Inventive Step) (Patently-O) (Holman's Biotech IP Blog) (Patent Docs) (Ladas & Parry) (Tech Transfer Blog) (ipwars.com) (Ars Technica) (BlawgIT) (IP Watch) (The Prior Art) US: Study suggests USPTO erred in broad claims of Myriad BRCA1 patent (Tech Transfer Blog) (Patent Docs) US: CAFC confirms written description requirement in Ariad v Lilly (IP Law Blog) (IP Osgoode) (IP Spotlight) (Ars Technica) US:… [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification… [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification… [read post]
17 Feb 2010, 3:17 am
Both were on display in last week’s 8th District decision in State v. [read post]
11 Jan 2010, 4:08 pm
Riyad; Eureka Water Co. v. [read post]
8 Jul 2009, 7:04 am
– CAFC decision in Agilent Techs v Affymetrix concerning claims pertaining to ‘microarray hybridization’ (Gray on Claims) US: Counterclaims dismissed in Alzheimer’s Institute/ Mayo patent licensing dispute over transgenic mice (Patent Docs) Products (Tavanic) Levofloxacin – UK: EWCA upholds decision that Daiichi’s Levofloxacin patent and SPC both invalid: Generics (UK) Ltd v Daiichi Pharmaceutical Co… [read post]
9 Apr 2009, 9:27 am
T-Online.de AG & Co. [read post]
